Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The AIDS epidemic

M A Conant1

  • 1Department of Dermatology, University of California, San Francisco.

Journal of the American Academy of Dermatology
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

New fungal infections, both skin and systemic, are emerging clinical markers for progressive human immunodeficiency virus (HIV) infection. Monitoring these alongside CD4 cell counts aids in evaluating HIV progression and managing opportunistic infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Screening and therapy of anal intraepithelial neoplasia (AIN) and anal carcinoma in patients with HIV-infection].

Deutsche medizinische Wochenschrift (1946)·2003
Same author

Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials.

International journal of STD & AIDS·2002
Same author

Immunomodulatory therapy in the management of viral infections in patients with HIV infection.

Journal of the American Academy of Dermatology·2000
Same author

Persistent stress as a predictor of genital herpes recurrence.

Archives of internal medicine·2000
Same author

A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.

AIDS (London, England)·1999
Same author

HIV related skin diseases clear with combination therapy.

The Western journal of medicine·1998
Same journal

Dermatologic conditions associated with HIV among US adults across different racial and ethnic groups: A retrospective cohort study using TriNetX.

Journal of the American Academy of Dermatology·2026
Same journal

Ethical Considerations in Same-Day Surgical Treatment of a High-Risk, Poorly Differentiated Squamous Cell Carcinoma.

Journal of the American Academy of Dermatology·2026
Same journal

The Ethics of the Handshake in Dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Dermatology images: Hidradenitis suppurativa.

Journal of the American Academy of Dermatology·2026
Same journal

Response to Guo et al., "Response to Huang et al.'s 'Real-world efficacy and safety of tofacitinib on the progression of skin sclerosis in patients with systemic sclerosis: an analysis of national multicenter data from the CRDC.'".

Journal of the American Academy of Dermatology·2026
Same journal

Genomic Predictors of Perineural Invasion in Cutaneous Squamous Cell Carcinoma: Insights from an MD Anderson Cohort.

Journal of the American Academy of Dermatology·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Immunology
  • Dermatology

Background:

  • The clinical presentation of human immunodeficiency virus (HIV) infection is dynamic.
  • Classic markers for progressive HIV infection include Kaposi's sarcoma, Pneumocystis carinii pneumonia, Mycobacterium avium intercellulare infections, and cryptococcal meningitis.

Purpose of the Study:

  • To identify and categorize new opportunistic fungal infections associated with HIV.
  • To highlight the correlation between fungal disease presentation and CD4 cell counts in HIV patients.
  • To emphasize the role of cutaneous manifestations in assessing HIV disease progression.

Main Methods:

  • Review of clinical presentations in evolving HIV infection.
  • Identification of emerging cutaneous and systemic opportunistic fungal infections.

Related Experiment Videos

  • Correlation analysis between fungal disease onset and CD4+ T-cell counts.

    • Main Results:

    • New cutaneous fungal infections (seborrheic dermatitis, onychomycosis, tinea pedis) and systemic fungal infections (Aspergillus fumigatus, Penicillium marneffei) are now recognized.
    • The incidence of many fungal infections correlates with declining CD4 cell counts.
    • Cutaneous signs are significant indicators of HIV disease progression.

    Conclusions:

    • Emerging fungal infections provide valuable clinical markers for HIV progression.
    • CD4 cell count monitoring alongside these fungal markers aids patient evaluation.
    • Prophylaxis for opportunistic infections improves life expectancy in patients with acquired immunodeficiency syndrome (AIDS).